68 related articles for article (PubMed ID: 4225560)
1. A controlled comparison of 5-fluoro-2'-deoxyuridine therapy administered by rapid intravenous injection and by continuous intravenous infusion.
Moertel CG; Reitemeier RJ; Hahn RG
Cancer Res; 1967 Mar; 27(3):549-52. PubMed ID: 4225560
[No Abstract] [Full Text] [Related]
2. A comparison of 5-fluorouracil administered by slow infusion and rapid injection.
Moertel CG; Schutt AJ; Reitemeier RJ; Hahn RG
Cancer Res; 1972 Dec; 32(12):2717-9. PubMed ID: 4566290
[No Abstract] [Full Text] [Related]
3. Continuous intravenous infusions of 5-fluoro-2'-deoxyuridine in the treatment of solid tumors.
DeConti RC; Kaplan SR; Papac RJ; Calabresi P
Cancer; 1973 Apr; 31(4):894-8. PubMed ID: 4267531
[No Abstract] [Full Text] [Related]
4. Combination chemotherapy in gastrointestinal cancer.
Reitemeier RJ; Moertel CG; Hahn RG
Cancer Res; 1970 May; 30(5):1425-8. PubMed ID: 4246651
[No Abstract] [Full Text] [Related]
5. 5-fluorouracil intravenous infusion for 48 hours, repeated every two weeks.
Hill GJ; Grage TB; Wilson W; Ansfield FJ
J Surg Oncol; 1972; 4(1):60-70. PubMed ID: 5033956
[No Abstract] [Full Text] [Related]
6. A clinical study of fluorouracil.
Nadler SH; Moore GE
Surg Gynecol Obstet; 1968 Dec; 127(6):1210-4. PubMed ID: 4882472
[No Abstract] [Full Text] [Related]
7. The variability of individual tolerance to methotrexate in cancer patients.
Hansen HH; Selawry OS; Holland JF; McCall CB
Br J Cancer; 1971 Jun; 25(2):298-305. PubMed ID: 4256007
[TBL] [Abstract][Full Text] [Related]
8. Phase II study of camptothecin (NSC-100880) in the treatment of advanced gastrointestinal cancer.
Moertel CG; Schutt AJ; Reitemeier RJ; Hahn RG
Cancer Chemother Rep; 1972 Feb; 56(1):95-101. PubMed ID: 5030811
[No Abstract] [Full Text] [Related]
9. [Efficacy and safety of two methods of administration of granisetron injection for nausea and vomiting induced by chemotherapy for tumors in hematopoietic organs--a randomized crossover comparison between intravenous drip infusion and intravenous bolus injection].
Tsudo M; Moriguchi T
Gan To Kagaku Ryoho; 1998 Sep; 25(11):1747-53. PubMed ID: 9757201
[TBL] [Abstract][Full Text] [Related]
10. Toxicity studies of fluorouracil used with adrenalectomy in breast cancer.
Piro AJ; Wilson RE; Hall TC; Aliapoulios MA; Nevinny HB; Moore FD
Arch Surg; 1972 Jul; 105(1):95-9. PubMed ID: 5031606
[No Abstract] [Full Text] [Related]
11. Chemotherapy of large bowel cancer.
Davis HL
Cancer; 1982 Dec; 50(11 Suppl):2638-46. PubMed ID: 6215979
[No Abstract] [Full Text] [Related]
12. Phase I study of continuous venous infusion of floxuridine (5-FUDR) chemotherapy.
Lokich JJ; Sonneborn H; Paul S; Zipoli T
Cancer Treat Rep; 1983 Sep; 67(9):791-3. PubMed ID: 6224555
[TBL] [Abstract][Full Text] [Related]
13. Clinical evaluation of 5-bromo-5-fluoro-6-methoxy-dihydro-2'-deoxyuridine.
Van Dyk JJ; Clarkson BD; Duschinsky R; Keller O; La Sala E; Krakoff IH
Cancer Res; 1967 Nov; 27(11):2129-36. PubMed ID: 4294532
[No Abstract] [Full Text] [Related]
14. [Preliminary results of clinical trial of the antineoplastic antibiotic bruneomycin].
Garim AM; Lorie IuI; Reĭzinger MA; Shkarenkov VA; Durnov LA
Antibiotiki; 1967 Jul; 12(7):609-19. PubMed ID: 4299328
[No Abstract] [Full Text] [Related]
15. [1st experiences in the treatment of ovarian tumors with Peptichemio].
Natale N; Mangioni C; Remotti G
Minerva Med; 1974 May; 65(33):1805-10. PubMed ID: 4367233
[No Abstract] [Full Text] [Related]
16. THE PHYSIOLOGIC DISPOSITION OF 5-FLUOROURACIL AND 5-FLUORO-2'-DEOXYURIDINE IN MAN.
CLARKSON B; O'CONNOR A; WINSTON L; HUTCHISON D
Clin Pharmacol Ther; 1964; 5():581-610. PubMed ID: 14209775
[No Abstract] [Full Text] [Related]
17. Chronic infusion of 5-fluoro-2'-deoxyuridine (5-FUDR) into the hepatic artery of the dog.
Khazei AM; Patel DD; Morgenthaler FR; MacDonald AJ; Sanadizadeh SM; Watkins E
J Surg Res; 1970 Aug; 10(8):343-52. PubMed ID: 4193563
[No Abstract] [Full Text] [Related]
18. [A late phase II trial of l-leucovorin and 5-fluorouracil in advanced colorectal cancer. l-Leucovorin and 5-FU Study Group (Japan Western Group)].
Konishi K; Yabushita K; Taguchi T; Ota J; Takashima S; Abe T; Kikkawa N; Yasutomi M; Sowa M; Maehara Y
Gan To Kagaku Ryoho; 1995 Jun; 22(7):925-32. PubMed ID: 7793998
[TBL] [Abstract][Full Text] [Related]
19. [10 years of L-DOPA therapy of Parkinson's syndrome].
Birkmayer W
Wien Klin Wochenschr; 1971 Apr; 83(13):221-7. PubMed ID: 4254333
[No Abstract] [Full Text] [Related]
20. Pulmonary toxicity of continuous infusion 5-fluoro-2'-deoxyuridine.
Chu SI; Kim HJ; Skubitz KM
Anticancer Drugs; 1995 Jun; 6(3):475-8. PubMed ID: 7670148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
